Antibody therapy may prevent Kawasaki heart damage
Large doses of gamma globulin given to young Kawasaki syndrome patients can largely prevent heart artery damage, potentially cutting future morbidity and mortality by about fivefold. The study in New England Journal of Medicine covered six U.S. hospitals, with experts cautioning that the experimental gamma globulin isn’t FDA approved and costs may influence who receives treatment.
MENTIONED IN THIS ARTICLE
Boston
Jane W Newburger
Children’s Hospital
Alan Rauch
U.S
Centers For Disease Control
Auanta
Newburger
United States
Marian E. Melish
University of Hawaii
New England Journal of Medicine
Also Mentioned on This Page
the News
Frederick MO
US Food and Drug Administration
Melish
Ralph B. Feigin
Kary] S. Barron
Baylor College
Saab Buyers
Subaru
Lila Care
Talore Kettle
Urbana Pike
Frederick
THE
Price Beater
Stretiing
Chevrolet-Cadkx. Inc
Baughman
Maryland
Reponse Analysis
News-Post
Edward F. Mull
Frederick News-Post
East
Patrick Street